@misc{Twardowski_Tomasz_GMO_2009,
 author={Twardowski, Tomasz},
 number={5},
 copyright={Creative Commons Attribution BY-SA 4.0 license},
 journal={Biotechnologia 5 (2009)-.},
 howpublished={online},
 year={2009},
 publisher={Committee on Biotechnology PAS},
 publisher={Institute of Bioorganic Chemistry PAS},
 language={pol},
 abstract={Genetically modified organisms are the key step for innovative medicines. The innovative drugs in the 21*' century will be in the majority of proteins, nucleic acids and their combinations. The critical issues in case of biopharmaceuticals are quality and reproducibility of production. These aspects are evident in biosimilars (generics) and protection of intellectual property rights.},
 title={GMO - innovative biotechnology in 21st century medicine},
 type={Text},
 URL={http://rcin.org.pl/Content/72132/PDF/POZN271_94539_biotechnologia-2009-no5-twardowski.pdf},
 keywords={biotechnology},
}